An Isotonic Drink Containing Pacific Cod ( Gadus macrocephalus ) Processing Waste Collagen Hydrolysate for Bone and Cartilage Health.
Nikita Yu ZarubinElena N KharenkoOlga V BredikhinaElizaveta V LavrukhinaKira S RysakovaVitaliy Yu NovikovGeorgy E LeonovIgor V VakhrushevKonstantin V ZolotarevAnton N MikhailovMarina V MikhailovaPublished in: Marine drugs (2024)
Malnutrition is one of the major factors of bone and cartilage disorders. Pacific cod ( Gadus macrocephalus ) processing waste is a cheap and highly promising source of bioactive substances, including collagen-derived peptides and amino acids, for bone and cartilage structure stabilization. The addition of these substances to a functional drink is one of the ways to achieve their fast intestinal absorption. Collagen hydrolysate was obtained via enzymatic hydrolysis, ultrafiltration, freeze-drying, and grinding to powder. The lyophilized hydrolysate was a light gray powder with high protein content (>90%), including collagen (about 85% of total protein) and a complete set of essential and non-essential amino acids. The hydrolysate had no observed adverse effect on human mesenchymal stem cell morphology, viability, or proliferation. The hydrolysate was applicable as a protein food supply or a structure-forming food component due to the presence of collagen fiber fragments. An isotonic fitness drink (osmolality 298.1 ± 2.1 mOsm/L) containing hydrolysate and vitamin C as a cofactor in collagen biosynthesis was prepared. The addition of the hydrolysate did not adversely affect its organoleptic parameters. The production of such functional foods and drinks is one of the beneficial ways of fish processing waste utilization.
Keyphrases
- amino acid
- tissue engineering
- wound healing
- bone mineral density
- heavy metals
- public health
- mesenchymal stem cells
- endothelial cells
- extracellular matrix
- body composition
- stem cells
- signaling pathway
- bone marrow
- bone loss
- drinking water
- mental health
- physical activity
- risk assessment
- human health
- postmenopausal women
- binding protein
- electronic health record
- cell therapy